Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : électronique
Titre(s) : Anticancer drug development [Texte électronique] / edited by Bruce C. Baguley, David J. Kerr
Publication : San Diego : Academic Press, cop. 2002
Description matérielle : 1 ressource dématérialisée
Note(s) : Bruce C. Baguley is a New Zealander. - Includes bibliographical references and index
Autre(s) auteur(s) : Baguley, Bruce C.. Fonction indéterminée
Kerr, David J. (1956-....). Fonction indéterminée
Sujet(s) : Anticancéreux
Chimiothérapie anticancéreuse
Médicaments
Indice(s) Dewey :
616.994 061 (23e éd.) = Cancers (médecine) - Pharmacothérapie
Identifiants, prix et caractéristiques : ISBN 9780120726516
Identifiant de la notice : ark:/12148/cb446306339
Notice n° :
FRBNF44630633
(notice reprise d'un réservoir extérieur)
Table des matières : A brief history of cancer chemotherapy ; Novel targets in the cell cycle and cell
cycle checkpoints ; Growth factor and signal transduction targets for cancer therapy
; Cell death pathways as targets for anticancer drugs ; Drug resistance pathways
as targets ; Role of matrix metalloproteinases and plasminogen activators in cancer
invasion and metastasis: therapeutic strategies ; Tumor vasculature as a target ;
Gene-directed enzyme prodrug therapy ; Tumor antigens as targets for anticancer drug
development ; Structure-based drug design and its contributions to cancer chemotherapy
; The contribution of synthetic organic chemistry to anticancer drug development
; Biosynthetic products for anticancer drug design and treatment: the bryostatins
; DNA-encoded peptide libraries and drug discovery ; Mechanism-based high-throughput
screening for novel anticancer drug discovery ; Tumor cell cultures in drug development
; Screening using animal systems ; Relevance of preclinical
